News from kalobios pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 10, 2015, 08:01 ET
KaloBios logo

KaloBios Reports Second Quarter Financial Results and Provides Clinical Update

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), a monoclonal antibody company focused on oncology, today announced its financial results for...

Jul 29, 2015, 13:00 ET
KaloBios logo

KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), a monoclonal antibody company focused on developing innovative therapies to benefit patients...

Jul 29, 2015, 10:16 ET
KaloBios logo.

KaloBios Regains Compliance with NASDAQ Minimum Bid Price Requirement

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), a monoclonal antibody company focused on developing innovative therapies to benefit patients with...

Jul 13, 2015, 08:01 ET
KaloBios logo.

KaloBios Announces Shareholders and Board of Directors Approval of Reverse Stock Split

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), a monoclonal antibody company focused on developing innovative therapies to benefit patients...

Jun 17, 2015, 13:30 ET
KaloBios logo.

KaloBios to Present at the JMP Securities Life Sciences Conference

SOUTH SAN FRANCISCO, Calif., June 17, 2015 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that it will present...

May 28, 2015, 16:01 ET
KaloBios logo.

KaloBios Appoints Ronald A. Martell Executive Chairman

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the appointment of Ronald A. Martell, to the position of Executive Chairman. Mr....

May 11, 2015, 08:01 ET
KaloBios logo.

KaloBios Reports First Quarter 2015 Financial Results

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today reported its financial results for the first quarter of 2015. Net loss for the quarter ended...

Apr 22, 2015, 18:00 ET
KaloBios logo.

KaloBios Elects Ronald A. Martell to Board of Directors

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the election of veteran biopharmaceutical industry executive, Ronald A. Martell,...

Apr 06, 2015, 08:01 ET
KaloBios logo.

KaloBios to Present at the 14th Annual Needham Healthcare Conference

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that it will present at the 14th Annual Needham Healthcare Conference in New...

Mar 16, 2015, 14:47 ET
KaloBios logo.

KaloBios Reports Fourth Quarter 2014 Financial Results

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today reported its financial results for the fiscal year 2014. Net loss for the fiscal year ended...

Feb 03, 2015, 16:01 ET
KaloBios logo.

KaloBios Announces Upcoming Investor Conference Participation

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that it will present at the BIO CEO & Investor Conference, and will participate...

Jan 08, 2015, 16:31 ET
KaloBios logo.

KaloBios Announces Retirement of David W. Pritchard, President and Chief Executive Officer

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that David W. Pritchard, president and chief executive officer, has decided to...

Jan 06, 2015, 16:01 ET
KaloBios logo.

KaloBios Reports Top-Line Data for Phase 2 Study of KB001-A to Treat Pseudomonas Aeruginosa Lung Infections in Cystic Fibrosis Patients

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced top-line data from the randomized, double-blind, placebo-controlled Phase 2 study of...

Dec 01, 2014, 08:05 ET
KaloBios logo.

KaloBios Elects Robert A. Baffi, BioMarin Senior Executive, to Board of Directors

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the election of Robert A. Baffi, Ph.D. to the KaloBios Board of Directors. Dr....

Nov 11, 2014, 16:05 ET
KaloBios logo.

KaloBios Announces Upcoming Scientific and Investor Conference Participation

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that it will present at the Stifel 2014 Healthcare Conference in November, and...

Nov 06, 2014, 16:05 ET
KaloBios logo

KaloBios Reports Third Quarter Financial Results

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today reported its financial results for the third quarter of 2014. Net loss for the three...

Aug 14, 2014, 08:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

Publication by KaloBios and Collaborators Shows EphA3 as Target for Highly Selective Anticancer Therapy

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the publication of preclinical findings describing EphA3 as a novel target...

Aug 07, 2014, 08:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Provides Clinical Update and Reports Second Quarter Financial Results

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today provided an update on its current clinical programs and announced financial results for...

Jul 28, 2014, 16:01 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Provides Update on KB001-A Partnership and Clinical Status

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today provided an update on the status of the KB001-A development program, including an update on its...

Jun 11, 2014, 14:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios to Present at 9th Annual JMP Securities Healthcare Conference

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company will be presenting at the following investor conference: The...